Fundraising FoxRibonaut Therapeutics
Jupiter, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into Ribonaut Therapeutics
Sign up to see every warm intro you have to Ribonaut Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ribonaut Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stealth company developing therapeutics for undruggable targets.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 1 round · 2022
▶$6.9MraisedJan 2023 · 6 investors · BiotechnologyRule 506(b)
▶$6.9MraisedJan 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary CollinsExecutive Officer
- Steven TregayDirector
- Matthew DisneyExecutive Officer, Director
- Lusong LuoDirector
- Jessica Childs-DisneyPromoter
- Offering amount
- $26M
- Amount sold
- $6.9M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ribonaut Therapeutics do?
- Stealth company developing therapeutics for undruggable targets.
- Who are Ribonaut Therapeutics's investors?
- Ribonaut Therapeutics's investors include Mission Biocapital.
- How much funding has Ribonaut Therapeutics raised?
- Ribonaut Therapeutics has disclosed $6.9M raised across 1 round.
- Where is Ribonaut Therapeutics headquartered?
- Ribonaut Therapeutics is headquartered in Jupiter, US.